These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35260194)

  • 41. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
    Chahine LM; Beach TG; Brumm MC; Adler CH; Coffey CS; Mosovsky S; Caspell-Garcia C; Serrano GE; Munoz DG; White CL; Crary JF; Jennings D; Taylor P; Foroud T; Arnedo V; Kopil CM; Riley L; Dave KD; Mollenhauer B;
    Neurology; 2020 Sep; 95(9):e1267-e1284. PubMed ID: 32747521
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
    Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
    PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease.
    Ma LY; Liu GL; Wang DX; Zhang MM; Kou WY; Feng T
    ACS Chem Neurosci; 2019 Feb; 10(2):812-823. PubMed ID: 30714719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.
    Price DL; Rockenstein E; Ubhi K; Phung V; MacLean-Lewis N; Askay D; Cartier A; Spencer B; Patrick C; Desplats P; Ellisman MH; Masliah E
    PLoS One; 2010 Nov; 5(11):e14020. PubMed ID: 21103359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
    Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
    Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease.
    Fricova D; Harsanyiova J; Kralova Trancikova A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. α-Syn overexpression, NRF2 suppression, and enhanced ferroptosis create a vicious cycle of neuronal loss in Parkinson's disease.
    A A; W C; N N; L M; M D; Zhang DD
    Free Radic Biol Med; 2022 Nov; 192():130-140. PubMed ID: 36150560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. α-Synuclein in cutaneous autonomic nerves.
    Wang N; Gibbons CH; Lafo J; Freeman R
    Neurology; 2013 Oct; 81(18):1604-10. PubMed ID: 24089386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
    Agliardi C; Meloni M; Guerini FR; Zanzottera M; Bolognesi E; Baglio F; Clerici M
    Neurobiol Dis; 2021 Jan; 148():105185. PubMed ID: 33217562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decrease in
    Han S; Seo MH; Lim S; Yeo S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of an Alternatively Spliced α-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis.
    Vinnakota RL; Yedlapudi D; Manda KM; Bhamidipati K; Bommakanti KT; RangaLakshmi GS; Kalivendi SV
    ACS Chem Neurosci; 2018 Dec; 9(12):2948-2958. PubMed ID: 29996045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease.
    Donadio V; Incensi A; Piccinini C; Cortelli P; Giannoccaro MP; Baruzzi A; Liguori R
    Ann Neurol; 2016 Feb; 79(2):306-16. PubMed ID: 26606657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease.
    Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A
    Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
    Zubelzu M; Morera-Herreras T; Irastorza G; Gómez-Esteban JC; Murueta-Goyena A
    Parkinsonism Relat Disord; 2022 Jun; 99():107-115. PubMed ID: 35717321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.